Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yesim Dargaud

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Research and Practice in Thrombosis and Haemostasis|February 17, 2023
Thrombin generation and implications for hemophilia therapies: A narrative reviewRobert F Sidonio, Maureane Hoffman, Gili Kenet, et al.
Blood Reviews|May 24, 2025
Unmet needs in hemophilic arthropathyYesim Dargaud, Sebastien Lobet, Nathalie Roussel, et al.
Seminars in Hematology|July 17, 2008
Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VIIYesim Dargaud, Jean-Claude Bordet, Anne Lienhart, et al.
Thrombosis Research|June 15, 2024
Liver health in hemophilia in the era of gene therapyYesim Dargaud, Massimo Levrero, François Bailly, et al.
Thrombosis and Haemostasis|July 22, 2016
Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literatureSandra Le Quellec, Jean-Claude Bordet, Claude Negrier, et al.
Haematologica|February 15, 2024
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapyYesim Dargaud, Alexandre Leuci, Alejandra Reyes Ruiz, et al.
International Journal of Laboratory Hematology|October 13, 2021
The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapyRemi Benoit, Christophe Nougier, Helene Desmurs-Clavel, et al.
Thrombosis Research|August 5, 2008
Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women. A rebuttalYesim Dargaud, Lucia Rugeri, Claude Négrier, et al.
Research and Practice in Thrombosis and Haemostasis|April 11, 2024
<i>In vitro</i> effect of hydroxyethyl starch on COVID-19 patients-associated hypofibrinolytic stateHamdi Rezigue, Michel Hanss, Jean-Stéphane David, et al.
Thrombosis Research|May 21, 2025
In vitro effects of Mim8 and combined Mim8-bypassing therapy on thrombin generation, thromboelastography and fibrin clot ultrastructureHamdi Rezigue, Laurie Josset, Christophe Nougier, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Research and Practice in Thrombosis and Haemostasis|February 17, 2023
Thrombin generation and implications for hemophilia therapies: A narrative reviewRobert F Sidonio, Maureane Hoffman, Gili Kenet, et al.
Blood Reviews|May 24, 2025
Unmet needs in hemophilic arthropathyYesim Dargaud, Sebastien Lobet, Nathalie Roussel, et al.
Seminars in Hematology|July 17, 2008
Use of the thrombin generation test to evaluate response to treatment with recombinant activated factor VIIYesim Dargaud, Jean-Claude Bordet, Anne Lienhart, et al.
Thrombosis Research|June 15, 2024
Liver health in hemophilia in the era of gene therapyYesim Dargaud, Massimo Levrero, François Bailly, et al.
Thrombosis and Haemostasis|July 22, 2016
Comparison of current platelet functional tests for the assessment of aspirin and clopidogrel response. A review of the literatureSandra Le Quellec, Jean-Claude Bordet, Claude Negrier, et al.
Haematologica|February 15, 2024
Efanesoctocog alfa: the renaissance of Factor VIII replacement therapyYesim Dargaud, Alexandre Leuci, Alejandra Reyes Ruiz, et al.
International Journal of Laboratory Hematology|October 13, 2021
The modification of the thrombin generation assay for the clinical assessment of hypercoagulability in patients receiving heparin therapyRemi Benoit, Christophe Nougier, Helene Desmurs-Clavel, et al.
Thrombosis Research|August 5, 2008
Feasibility of an easy-to-use risk score in the prevention of venous thromboembolism and placental vascular complications in pregnant women. A rebuttalYesim Dargaud, Lucia Rugeri, Claude Négrier, et al.
Research and Practice in Thrombosis and Haemostasis|April 11, 2024
<i>In vitro</i> effect of hydroxyethyl starch on COVID-19 patients-associated hypofibrinolytic stateHamdi Rezigue, Michel Hanss, Jean-Stéphane David, et al.
Thrombosis Research|May 21, 2025
In vitro effects of Mim8 and combined Mim8-bypassing therapy on thrombin generation, thromboelastography and fibrin clot ultrastructureHamdi Rezigue, Laurie Josset, Christophe Nougier, et al.
Pageof 13